home / news / Study team co-investigators updated

Open Call for Abstracts: 41st EuroQol Plenary 2024

February 26, 2024
The Call for Abstracts for the 41st EuroQol Plenary 2024...

New Members joined the EuroQol Group Association

February 20, 2024
In 2024, four new members have joined the EuroQol Group...

The 17th Joint Call for Proposals by the EuroQol Working Groups is now OPEN!

February 20, 2024
The 17th Joint Call for Proposals by the EuroQol Working...

Our Monthly Scientific Selection: January Publications on EuroQol Instruments

February 19, 2024
[1-31 January 2024] 1. Stenson K, Fecteau TE, O'Callaghan L,...

Our Monthly Scientific Selection: December Publications on EuroQol Instruments

January 22, 2024
[1-31 December 2023] 1. Blackmore AM, Mulhern B, Norman R,...
August 16, 2022

Study team co-investigators updated

The research team for the UK EQ-5D-5L valuation study has been updated. The lead investigator is Donna Rowen (School of Health and Related Research, University of Sheffield) and co-investigators are:

  • Nathan Bray (Centre for Health Economics and Medicines Evaluation, Bangor University)
  • Jill Carlton (School of Health and Related Research, University of Sheffield)
  • Louise Longworth (PHMR, London)
  • David Meads (Academic Unit of Health Economics, Leeds Institute for Health Sciences, University of Leeds)
  • Clara Mukuria (School of Health and Related Research, University of Sheffield)
  • Ciaran O’Neill (Centre for Public Health, Queens University Belfast)
  • Yaling Yang (Nuffield Department of Primary Care Health Sciences, University of Oxford)

This team has been carefully selected by the project’s Steering Group and will bring significant experience and expertise to the valuation study.